Identification of Susceptibility to Malignant Hyperpyrexia

Moulds, R. F. W.; Denborough, M. A.
May 1974
British Medical Journal;5/4/1974, Vol. 2 Issue 5913, p245
Academic Journal
No abstract available.


Related Articles

  • Cot death clue.  // New Scientist;7/13/96, Vol. 151 Issue 2038, p11 

    Reports on an Australian study implicating a hereditary muscle disease in cot death. Death of piglets born with malignant hyperpyrexia when the temperature in their incubators was raised; Risk of cot death in infants with malignant hyperpyrexia.

  • CORRESPONDENCE. Lloyd, June K.; Harris, R.I.; Edmonds, C.J.; Woodrow, J.C.; Lack, J.A.; Braveman, A.M.; Lloyd, W.H.; Elder, G.H.; Magnus, I.A.; Canellos, G.P.; Loughnane, T.; McKenzie, Sheila A.; Isaacs, P.E.T.; Warhurst, D.C.; Spalding, J.M.K.; McNulty, J.G.; Lewis, A.A.; Addenbrooke, D.R.H. // British Medical Journal;1/4/1975, Vol. 1 Issue 5948, p35 

    Presents medical correspondence related to medicine. Emphasis on the chronic diuretic therapy and potassium; Cause of malignant hyperpyrexia; Analysis on the geriatric policies.

  • CORRESPONDENCE.  // British Medical Journal;2/22/1975, Vol. 1 Issue 5955, p453 

    Presents several issues related to medicine in Great Britain. Shortage of organs for transplantation; Deaths in dental chair; Effects of the malignant hyperpyrexia.

  • Isoflurane.  // Reactions Weekly;Sep2015, Vol. 1569 Issue 1, p137 

    The article presents a case study of a 13-year-old boy who developed malignant hyperpyrexia after isoflurane treatment.

  • Malignant hyperthermia. Neacsu, Ancuta // Nursing Standard;3/22/2006, Vol. 20 Issue 28, p51 

    Malignant hyperthermia, also known as malignant hyperpyrexia, is a pharmacogenetic condition which can develop during general anaesthesia and can be fatal. The author suggests that more awareness of the condition is needed by ward-based nurses who are involved with patients undergoing surgery....

  • Evaluation of Creatinine Phosphokinase in Screening Patients for Malignant Hyperpyrexia. Ellis, F. Richard; Clarke, I.M.C.; Modgill, Margaret; Currie, S.; Harriman, D.G.F. // British Medical Journal;8/30/1975, Vol. 3 Issue 5982, p511 

    Evaluates the effectiveness of creatinine phosphokinase (CPK) on screening patients with malignant hyperpyrexia in England. Correlation between the disease and myopathy; Symptoms of the disease; Assessment on the different CPK values at different times.

  • Future goal for melanoma screening is identification of genotypic markers. Guttman, Cheryl // Dermatology Times;May95, Vol. 16 Issue 5, pS7 

    Reports on the development of genotypic markers to provide a precise way to identify persons at risk for malignant melanoma. Panel of probes covering all known mutations causing melanoma; Identification of individuals who harbor a genetic susceptibility.

  • What does it mean to be a cancer gene carrier? Problems in establishing causality from the... Schatzkin, Arthur; Goldstein, Alisa // JNCI: Journal of the National Cancer Institute;8/2/95, Vol. 87 Issue 15, p1126 

    Discusses factors of being a cancer gene carrier. Identification of genes that impart susceptibility to colorectal, breast and ovarian cancers; Development of malignant disease; Protection from cancer by nutritional, pharmacologic and other interventions; Unknown excess risk of malignancy among...

  • Hereditary prostate cancer: a new piece of the puzzle. Borg, Ake // Nature Medicine;Feb2001, Vol. 7 Issue 2, p153 

    Reports findings of a study on the hereditary prostrate cancer, which is claimed to be most common malignancy in North American and European man. Characteristics of prostrate cancer; Heterogeneity of the hereditary form of prostrate cancer; Identification of a candidate prostrate cancer...

  • Association of candidate gene polymorphisms and TGF-beta/IL-10 levels with malaria in three regions of Cameroon: a case-control study. Apinjoh, Tobias O.; Anchang-Kimbi, Judith K.; Njua-Yafi, Clarisse; Ngwai, AndrĂ© N.; Mugri, Regina N.; Rockett, Kirk A.; Kwiatkowski, Dominic P.; Achidi, Eric A.; Clark, Taane G. // Malaria Journal;2014, Vol. 13 Issue 1, p1 

    Background Plasmodium falciparum malaria is one of the most widespread and deadliest infectious diseases in children under five years in endemic areas. The disease has been a strong force for evolutionary selection in the human genome, and uncovering the critical host genetic factors that confer...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics